Cargando…

A rapid and flexible microneutralization assay for serological assessment of influenza viruses

BACKGROUND: Serological responses from influenza vaccination or infection are typically measured by hemagglutinin inhibition (HAI) or microneutralization (MN). Both methods are limited in feasibility, standardization, and generalizability to recent strains. We developed a luciferase MN (LMN) assay t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rumfelt, Kalee E., Fitzsimmons, William J., Truscon, Rachel, Monto, Arnold S., Martin, Emily T., Lauring, Adam S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174083/ https://www.ncbi.nlm.nih.gov/pubmed/37127782 http://dx.doi.org/10.1111/irv.13141

Ejemplares similares

An In Vitro Microneutralization Assay for Influenza Virus Serology
por: Cuevas, Frans, et al.
Publicado: (2022)

302. Investigating NAI Titer as a Neutralizing IAV Correlate of Protection
por: Rumfelt, Kalee E, et al.
Publicado: (2023)

Vaccination has minimal impact on the intrahost diversity of H3N2 influenza viruses
por: Debbink, Kari, et al.
Publicado: (2017)

Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts
por: Valesano, Andrew L., et al.
Publicado: (2021)

Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts
por: Valesano, Andrew L., et al.
Publicado: (2021)

SARS-CoV-2-Neutralizing Antibody Response and Correlation of Two Serological Assays with Microneutralization
por: Souiri, Amal, et al.
Publicado: (2023)

Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays
por: Morrison, Brian J., et al.
Publicado: (2018)

Comparability of Titers of Antibodies against Seasonal Influenza Virus Strains as Determined by Hemagglutination Inhibition and Microneutralization Assays
por: Heeringa, Marten, et al.
Publicado: (2020)

SARS-CoV-2 Total and Subgenomic RNA Viral Load in Hospitalized Patients
por: Dimcheff, Derek E., et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 Total and Subgenomic RNA Viral Load in Hospitalized Patients
por: Dimcheff, Derek E, et al.
Publicado: (2021)

An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study
por: Waldock, Joanna, et al.
Publicado: (2023)

Stochastic processes constrain the within and between host evolution of influenza virus
por: McCrone, John T, et al.
Publicado: (2018)

Immunogenicity and safety of influenza vaccination in patients with juvenile idiopathic arthritis on biological therapy using the microneutralization assay
por: Camacho-Lovillo, M. S., et al.
Publicado: (2017)

The Mutational Robustness of Influenza A Virus
por: Visher, Elisa, et al.
Publicado: (2016)

Development of a High-Throughput Respiratory Syncytial Virus Fluorescent Focus-Based Microneutralization Assay
por: Shambaugh, Cindy, et al.
Publicado: (2017)

Evaluation of MERS-CoV Neutralizing Antibodies in Sera Using Live Virus Microneutralization Assay
por: Algaissi, Abdullah, et al.
Publicado: (2019)

Novel microneutralization assay for HCMV using automated data collection and analysis
por: Abai, Anna Maria, et al.
Publicado: (2007)

Evaluation of immunogenicity of the 2008-2009 seasonal influenza vaccines by microneutralization test
por: Kim, Seung Youn, et al.
Publicado: (2012)

Development of an improved microneutralization assay for respiratory syncytial virus by automated plaque counting using imaging analysis
por: Zielinska, Edyta, et al.
Publicado: (2005)

A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines
por: Zhao, Hui, et al.
Publicado: (2018)

A high throughput reporter virus particle microneutralization assay for quantitation of Zika virus neutralizing antibodies in multiple species
por: Bohning, Kelly, et al.
Publicado: (2021)

Epistatic Interactions within the Influenza A Virus Polymerase Complex Mediate Mutagen Resistance and Replication Fidelity
por: Pauly, Matthew D., et al.
Publicado: (2017)

Use of a Blockade-of-Binding ELISA and Microneutralization Assay to Evaluate Zika Virus Serostatus in Dengue-Endemic Areas
por: Nascimento, Eduardo J. M., et al.
Publicado: (2019)

Microneutralization Assay Titres Correlate with Protection against Seasonal Influenza H1N1 and H3N2 in Children
por: Verschoor, Chris P., et al.
Publicado: (2015)

Rapid transmission and tight bottlenecks constrain the evolution of highly transmissible SARS-CoV-2 variants
por: Bendall, Emily E., et al.
Publicado: (2022)

Effectiveness of Influenza Vaccines in the HIVE Household Cohort Over 8 Years: Is There Evidence of Indirect Protection?
por: Malosh, Ryan E, et al.
Publicado: (2021)

Correction: Microneutralization Assay Titres Correlate with Protection against Seasonal Influenza H1N1 and H3N2 in Children
por: Verschoor, Chris P., et al.
Publicado: (2016)

Rapid transmission and tight bottlenecks constrain the evolution of highly transmissible SARS-CoV-2 variants
por: Bendall, Emily E., et al.
Publicado: (2023)

Distinct influenza surveillance networks and their agreement in recording regional influenza circulation: Experience from Southeast Michigan
por: DeJonge, Peter M., et al.
Publicado: (2021)

Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore
por: Hsu, Jung Pu, et al.
Publicado: (2014)

Influenza Vaccination and Treatment with Antiviral Agents Among Hospitalized Adults in the 2014–2015 and 2015–2016 Influenza Seasons
por: E Segaloff, Hannah, et al.
Publicado: (2017)

A rapid real-time polymerase chain reaction-based live virus microneutralization assay for detection of neutralizing antibodies against SARS-CoV-2 in blood/serum
por: Abidi, Syed Hani, et al.
Publicado: (2021)

International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISE
por: Laurie, Karen L., et al.
Publicado: (2015)

Development of a Comparative European Orthohantavirus Microneutralization Assay With Multi- Species Validation and Evaluation in a Human Diagnostic Cohort
por: Hoornweg, Tabitha E., et al.
Publicado: (2020)

K‐medoids clustering of hospital admission characteristics to classify severity of influenza virus infection
por: Leis, Aleda M., et al.
Publicado: (2023)

Mutation and Epistasis in Influenza Virus Evolution
por: Lyons, Daniel M., et al.
Publicado: (2018)

Quantifying Protection Against Influenza Virus Infection Measured by Hemagglutination-inhibition Assays in Vaccine Trials
por: Zhao, Xiahong, et al.
Publicado: (2016)

The use of an in vitro microneutralization assay to evaluate the potential of recombinant VP5 protein as an antigen for vaccinating against Grass carp reovirus
por: He, Yongxing, et al.
Publicado: (2011)

Commentary: Development of a Comparative European Orthohantavirus Microneutralization Assay With Multi-Species Validation and Evaluation in a Human Diagnostic Cohort
por: Clement, Jan, et al.
Publicado: (2021)

Reproducibility of Serologic Assays for Influenza Virus A (H5N1)
por: Stephenson, Iain, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_noev4lpfj2h3hk8enqse9dlcq9